Stocks
JPMorgan's Stake in Cochlear Ltd Surges to 6.69%
JPMorgan Chase & Co. has increased its stake in Cochlear Ltd, a hearing implant manufacturer, from 5.51% to 6.69% of ordinary shares.
The change was recorded on August 11, 2026, and the latest notice shows that JPMorgan holds 4,377,207.50 ordinary shares, representing the increased voting power.
JPMorgan Chase Bank, N.A. is the largest single stakeholder, holding 2,998,765 ordinary shares as an agent lender for securities on loan.
The increase in JPMorgan's stake was due to various adjustments among its affiliates, including securities lending and investment management roles.